Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)

Molecular Psychiatry

Volumn 5, Issue 2, 2000, Pages 165-171

  Yoshikawa, T ^a   Padigaru, M ^a   Karkera, J D ^a   Sharma, M ^a   Berrettini, W H ^b   Esterling, L E ^a   Detera Wadleigh, S D ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Association; Bipolar affective disorder; Chromosome 18; Lithium; Polymorphism

Indexed keywords

COMPLEMENTARY DNA; ENZYME VARIANT; LITHIUM; MYOINOSITOL MONOPHOSPHATASE 2; PHOSPHATASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 18P; CLINICAL ARTICLE; ENZYME INHIBITION; GENE MAPPING; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOME; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MISSENSE MUTATION; MOLECULAR CLONING; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX;

EID: 0034106837     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000688     Document Type: Article

References (17)

1. 1 Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh SD, Nurnberger Jr JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918-5921.
2. 2 Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high density genome scan detects evidence for a bipolar-disorder susceptibility locus on chromosome 13q32, and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-5609.
3. 3 Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
4. 4 Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 marker in a sample of 57 German families. Mol Psychiatry 1999; 4: 76-84.
5. 5 Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD. A novel human myo-inositol monophosphatase gene, IMP. 18p, maps to a susceptibility region for bipolar disorder. Mol Psychiatry 1997; 2: 393-397.
6. 6 Sjoholt G, Molven A, Lovlie R, Wilcox A, Sikela JM, Steen VM. Genomic structure and chromosomal localization of human myoinositol monophosphatase gene (IMPA). Genomics 1997; 45: 113-122.
7. 7 Parthasarathy L, Vandal RE, Parthasarathy R, Devi CSS. Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase. Life Sci 1994; 54: 1127-1142.
8. 8 Atack JR. Inositol monophosphatase, the putative therapeutic target for lithium. Brain Res Rev 1996; 22: 183-190.
9. 9 NIMH Collaborative Group for Bipolar Disorder: Nurnberger JI Jr, DePaulo JR, Gershon ES, Reich T, Blehar M, Edenberg H, et al. A genomic survey of bipolar illness in the NIMH Genetics Initiative Pedigrees: a preliminary report. Am J Med Genet 1997; 74: 227-237.
10. 10 Neuwald AF, York JD, Majerus PW. Diverse proteins homologous to inositol monophosphatase. FEBS Lett 1991; 294: 16-18.
11. 11 Azizkhan JC, Jensen DE, Pierce AJ, Wade M. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit Rev Eukaryotic Gene Expression 1993; 3: 229-254.
12. 12 Dynan WS, Tjian R. Control of eukaryotic messenger RNA synthesis by sequence specific: DNA binding proteins. Nature 1985; 316: 774-778.
13. 13 Kadonaga JT, Jones KA, Tjian R. Promoter specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci 1986; 11: 20-23.
14. 14 Blake MC, Jambou RC, Swick AG, Kahn JW, Clifford J, Azizkhan JC. Transcriptional initiation is controlled by upstream GC-box interaction in a TATA-less promoter. Mol Cell Biol 1990; 10: 6632-6641.
15. 15 Olson EN. MyoD family, a paradigm for development? Genes Dev 1990; 4: 1454-1461.
16. 16 Imagawa M, Chiu R, Karin M. Transcription factor AP-2 mediates induction by two different signal-transcription pathways: protein kinase C and cAMP. Cell 1987; 51: 251-260.
17. 17 Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998; 63: 1139-1152.